The AfroCentric Group stands as Southern Africa’s largest, most diversified, and fully integrated healthcare company, driving sustainable impact through accessible, affordable, and quality healthcare solutions. Since its JSE listing in 2008, AfroCentric has expanded its footprint across the healthcare value chain, delivering innovative services through its subsidiaries in three key divisions: health administration and managed care, pharmaceutical solutions, and corporate solutions.

At the heart of the Group’s success is Medscheme, South Africa’s leading health risk management provider and medical scheme administrator, serving over 4 million lives through clients such as Fedhealth, GEMS, Polmed and many others. Complementing this are Klinikka, Aid for AIDS (AfA), and Denis, which further strengthen AfroCentric’s managed care expertise.

In pharmaceutical solutions, Pharmacy Direct leads as the country’s largest courier pharmacy, supported by Activo Health, Curasana, Forrester Pharma and Scriptpharm, ensuring end-to-end medicine supply and healthcare support. Meanwhile, Sanlam Health (formerly AfroCentric Corporate Solutions) oversees corporate wellness through AfroCentric Health Insure, EssentialMED, AfroCentric Wellness, Workcare, and Employee Health Services, integrating healthcare with financial security.

A transformative milestone came in May 2023 when Sanlam acquired a 60% majority stake, marking a new chapter in AfroCentric’s journey.

Today, AfroCentric continues to shape the future of African healthcare, combining its clinical excellence with Sanlam’s financial expertise to deliver holistic, sustainable wellbeing solutions.

Connect with us:
Website: www.afrocentric.za.com
LinkedIn: AfroCentric Group
Facebook: AfroCentric Group

Medscheme
Medscheme, South Africa’s largest health risk management provider and one of the country’s leading medical scheme administrators, for clients including Fedhealth, Medshield, Bonitas, GEMS, and Polmed, managing over four million lives.
Website: https://www.medscheme.com/
LinkedIn: Medscheme holdings